DoW Spinal Cord Injury, Clinical Trial Award
About
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of spinal cord injury (SCI). Distinctive Features: This funding opportunity contains an Early-Career Partnership Option, which allows for two Principal Investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the Initiating PI will submit a pre-application, but all PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn. Applications to this funding opportunity must name at least two spinal cord injury (SCI) community partners (e. g., SCI Lived-Experience Consultants, representatives of community-based organizations) who will provide advice and consultation throughout the planning and implementation of the research project.
The DoW Spinal Cord Injury, Clinical Trial Award is a federal funding opportunity designed to support researchers and organizations conducting clinical trials with the potential to significantly impact spinal cord injury (SCI) treatment and management. This grant is ideal for academic medical centers, research institutions, and clinical organizations committed to advancing SCI care through rigorous clinical research. The program emphasizes rapid implementation of promising interventions and welcomes collaborative research teams, including an innovative Early-Career Partnership Option that pairs established researchers with early-career investigators. A distinctive requirement ensures community engagement by mandating at least two spinal cord injury community partners—including individuals with lived SCI experience and representatives from community-based organizations—participate throughout the project planning and implementation. This grassroots involvement ensures research remains patient-centered and addresses real-world needs. Researchers should apply if they have feasible clinical trial protocols ready for implementation, access to patient populations, and commitment to meaningful community collaboration. The program operates on an annual cycle with applications due in November 2026. Organizations seeking to make a tangible difference in SCI treatment outcomes while advancing clinical science should review the official program guidelines for complete eligibility requirements and submission procedures.
Funding Facts
● Applications openDeadline
November 12, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle - contact program for FY26 amounts
Deadline
2026-11-12
Grant Type
federal
Application Cycle
Annual - FY2026 deadline November 12, 2026
Best For
Academic medical centers, clinical research organizations, and research institutions conducting spinal cord injury clinical trials with community engagement
Frequently Asked Questions
Who is eligible for DoW Spinal Cord Injury, Clinical Trial Award?
Eligibility criteria for this federal award typically include research institutions, academic medical centers, and clinical organizations capable of conducting rigorous clinical trials. The program offers an Early-Career Partnership Option allowing two Principal Investigators, with at least one being an early-career investigator. Applicants must also engage at least two spinal cord injury community partners throughout the project. For complete and current eligibility requirements, visit the official Department of War (DoW) or sponsoring federal agency website.
How much funding does DoW Spinal Cord Injury, Clinical Trial Award provide?
Specific funding amounts for this cycle are not currently listed. Award amounts typically vary based on project scope, duration, and research complexity. Contact the official program administrators or visit the DoW SCIRP website for current funding levels and budget guidance for the FY26 funding cycle.
How do I apply for DoW Spinal Cord Injury, Clinical Trial Award?
Applications follow a structured process: the Initiating Principal Investigator submits a pre-application first. If using the Early-Career Partnership Option, both the Initiating and Partnering PIs must submit full applications, with the Partnering PI providing an abbreviated submission focused on their specific research contribution. All applications must document engagement of at least two SCI community partners. Submit applications through the official federal grants portal by the November 12, 2026 deadline. Visit the official DoW SCIRP website for detailed application instructions and required forms.
What can DoW Spinal Cord Injury, Clinical Trial Award funding be used for?
This award supports the rapid implementation of clinical trials demonstrating significant potential to improve spinal cord injury treatment or management outcomes. Funding supports research projects that are ready for clinical implementation and include meaningful community partnership involvement. The award structure allows multiple PIs to receive separate awards if recommended for funding. For detailed information on allowable expenses and cost categories, consult the official program guidelines and SCIRP announcements.
Last updated: July 5, 2026